1: Global burden of diabetes and depression, Stefan F. Bornstein, Andreas Birkenfeld, and Julio Licinio
2: A lifecourse approach to understanding the association between depression and type 2 diabetes, Khalida Ismail, Calum D. Moulton, Andrea Danese, and Brenda W. Penninx
3: MicroRNAs as novel biomarkers in depression, diabetes and cardiovascular diseases, Henning Morawietz, Richard C. Siow, and Mohamad Musbah Almedawar
4: Genetics, Carol Kan and Ma-Li Wong
5: Innate immunity and inflammation in type 2 diabetes-associated depression, Calum D. Moulton and John Pickup
6: Hypothalamic-Pituitary-Adrenal (HPA) axis, Allan H. Young and Mario F. Jurena
7: Gut-brain axis: physiology, Carla Petrella, Giuseppe Nistico, and Robert Nistico
8: Diabetes distress, Norbert Hermanns, Marijke Bremmer, and Frank Snoek
9: The association between depression and cognitive impairment in type 2 diabetes, Calum Moulton and Clive Ballard
10: Treatment of depression in type 2 diabetes, Frank Petrak and Bonnie Röhrig
11: Risks and benefits of psychotropics, Andreas Barthel and Michael Bauer
12: Metabolic surgery and depression, Lidia Castagneto Gissey, James Casella Mariolo, Geltrude Mingrone, and Francesco Rubino
13: Novel pharmacological targets, Calum Moulton
14: Novel technologies, Harold Lebovitz and Shlomo Ben Haim
15: Current and emerging psychological models, Christopher Garrett
16: Targeting the circadian rhythm, Eleanor M Scott and Gregory Potter
17: Cultural and global perspectives, Kirsty Winkley, Ebaa Al-Ozairi, and Boon How Chew
18: National and international policy initiatives on multi-morbidity, Peter Schwarz and Patrick Timpel
- Written and edited by a team of internationally recognized clinicians
- Offers a unique perspective on the outstanding controversies of the epidemiology, mechanisms and treatment of the depression-type 2 diabetes comorbidity
Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are present, this poses a significant challenge to patients, clinicians, and health care systems globally.
Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes.
Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes.
Edited by Khalida Ismail, Professor of Psychiatry and Medicine, Department of Psychological Medicine Institute of Psychiatry, Psychology and Neuroscience King's College London, London, UK, Andreas Barthel, Associate Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany, Stefan R. Bornstein, Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany, and Julio Licinio, Deputy Director, College of Medicine, State University of New York, Upstate Medical University, Syracuse, USA